ClinicalTrials.gg
RecruitingNCT06769308SED_ICUUpdated Jan 10, 2025

Effect of Goal-directed Analgesia and Sedation Using EEG Derived QCON/qNOX in ICU Patients

An interventional study of Sedation titration according to qEEG and Sedation titration according to standard of care in Sedation Complication and Mechanical Ventilation Complication, sponsored by Università degli Studi di Ferrara. Recruiting at 2 sites in Italy. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2025-01-10.

Sponsored by Università degli Studi di Ferrara · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Registered 6 months after the study started (first participant enrolled Jan 2024, registered Jul 2024).
  • Started Jan 2024; still recruiting 2 years 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
174
Allocation
Randomized
Ages
18 Years to 90 Years
Sex
All
01

Study summary

Sedation and analgesia are fundamental tools for managing critical patients who require mechanical ventilation. However, recent scientific literature highlights that excessive sedation in these patients can increase the duration of mechanical ventilation and extend the overall length of stay in intensive care, as well as expose them to a higher risk of hypotension, venous thrombosis, and nosocomial pneumonia. The titration of sedation and analgesia in intensive care, on the other hand, is currently based primarily on clinical parameters (such as the onset of delirium, asynchronies with the ventilator, for example), which can lead to treatments not proportionate to the patient's needs.

The present study aims to evaluate the application, in an intensive care setting, of the Conox® system, a device already widely used in monitoring the anesthetic plan in the operating room. This tool would allow, through the processing of an EEG trace, the assessment of the level of sedation (qCON) and the probable algic response (qNOX), thus providing valuable information for the fine-tuning of the analgo-sedative plan.

02

Conditions studied

  • Sedation Complication
  • Mechanical Ventilation Complication

Keywords

  • ICU, sedation, analgesia, mechanical ventilation
03

In context

Lead sponsor

Università degli Studi di Ferrara is the lead sponsor of 65 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Age 18-90 years Admission to the ICU for less than 24 hours Expected mechanical ventilation for >48 hours Ongoing sedation

Exclusion criteria

Exclusion Criteria:

Mechanical ventilation (MV) for less than 48 hours Patient or next of kin refusal to participate > 35 Cerebrovascular disease Scheduled surgery Neuromuscular disease Presence of craniofacial trauma that prevents the placement of electrodes

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
174 participants (estimated)

Study arms

  • Active comparator
    Standard of care sedation

    The patients will be sedated according to the current standard of care (Behavioral pain scale and Richmond Agitation-Sedation Scale).

    Procedure: Sedation titration according to standard of care

  • Experimental
    EEG guided sedation

    The patients will be sedated according to the EEG derived indexes (qCON/qNOX).

    Device: Sedation titration according to qEEG

Interventions

  • DeviceSedation titration according to qEEG

    Sedation will be titrated according to the EEG derived indexes (qCON/qNOX)

  • ProcedureSedation titration according to standard of care

    Sedation will be provided according to the standard of care of the unit (clinical scales)

06

What researchers measure

Primary outcomes

  1. Ventilator free days

    The number of days without ventilation

    Time frame: Day 28

Secondary outcomes

  1. Delirium occurrence

    Occurrence of delirium

    Time frame: Daily after extubation

  2. ICU lenght of stay

    Lenght of stay in the intensive care unit

    Time frame: ICU discharge

  3. Drug consumption

    Evaluation of sedative drug consumption during ICU stay

    Time frame: ICU discharge

07

Study locations

1 of 2 sites recruiting
  • Azienda Ospedaliera Universitaria Sant'Anna
    Ferrara, 44100, Italy
    Recruiting
  • Azienda Ospedaliera Universitaria Federico II - "Policlinico"
    Napoli, Italy
    Not yet recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jan 2024 (actual). Primary completion is estimated for Dec 2026, 35 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 23, 2024
First posted
Jan 10, 2025
StartActual
Jan 1, 2024
Primary completionEst.
Dec 31, 2026
CompletionEst.
Jul 31, 2027
Last update
Jan 10, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 10, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06769308
Lead sponsor
Università degli Studi di Ferrara
Collaborators
Arcispedale S. Anna, Ferrara
Responsible party
Gaetano Scaramuzzo (Principal investigator, Università degli Studi di Ferrara) — Principal investigator
First posted
Jan 10, 2025
Start date
Jan 1, 2024
Primary completion
Dec 31, 2026 (estimated)
Completion
Jul 31, 2027 (estimated)
Last update
Jan 10, 2025

Study contacts

Gaetano Scaramuzzo, MD
Contact
scrgtn@unife.it
0532239158

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion